Worldwide Smart Inhalers Industry to 2025 - Rising Prevalence of Respiratory-Related Disorders is Driving Growth
21 avr. 2021 06h13 HE
|
Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Smart Inhalers Market (2020-2025) by Components, Product, Application, Distribution Channel, End-Use, Geography, Competitive Analysis and the...
Global Digital Respiratory Devices Market (2021 to 2030) - Featuring 3M, Adherium and Amiko Digital Health Among Others
16 avr. 2021 06h03 HE
|
Research and Markets
Dublin, April 16, 2021 (GLOBE NEWSWIRE) -- The "Global Digital Respiratory Devices Market 2021-2030: Focus on Sensors, Smart Inhalers & Nebulizers, Application, 9 Countries' Data, and...
Outlook on the Portable Compressor Nebulizer Global Market to 2025 - Cumulative Impact of COVID-19
22 mars 2021 09h08 HE
|
Research and Markets
Dublin, March 22, 2021 (GLOBE NEWSWIRE) -- The "Portable Compressor Nebulizer Market Research Report by Type (Mesh Nebulizer, Pneumatic Nebulizer, and Ultrasonic Nebulizer), by Distribution Channel...
With Monaghan Medical, Safe Nebulizer Therapy is Possible
23 févr. 2021 08h40 HE
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation wants you to know that you can create a safer environment when delivering nebulizer therapy. Nebulizer therapy is a...
Nasal delivery devices Market Forecast to 2027: Global COVID-19 Impact and Analysis by Drug Type, Delivery Technologies, End User
24 nov. 2020 02h48 HE
|
Research and Markets
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Nasal delivery devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type; Delivery Technologies; End User, and Geography"...
Global $39.96 Billion Pulmonary Devices Market to 2027: Consumables and Accessories to Grow at the Highest Rate
20 nov. 2020 07h33 HE
|
Research and Markets
Dublin, Nov. 20, 2020 (GLOBE NEWSWIRE) -- The "Pulmonary Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; Application; End User, and Geography" report has been added to...
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
13 nov. 2020 10h00 HE
|
InCarda Therapeutics, Inc.
Data Demonstrate Achievement of Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Study Findings Provide Proof of Concept for First-of-its-Kind Inhaled Antiarrhythmic for Treatment of...
InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing
21 oct. 2020 08h05 HE
|
InCarda Therapeutics, Inc.
Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2 Data Scheduled for...
Worldwide Industry for Aerosol Delivery Devices to 2027 - Increase in Prevalence of COPD and Asthma is Driving Growth
16 oct. 2020 05h28 HE
|
Research and Markets
Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Aerosol Delivery Devices Market by Product, Application and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report...
$248.22 Million Smart Inhalers Markets - Global Forecast to 2025 with COVID-19 Impact Assessment
16 oct. 2020 01h33 HE
|
Research and Markets
Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Smart Inhalers Market Research Report by Product Type, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has...